Lv1
38 积分 2024-02-27 加入
Abstract P5-05-24: RC48-ADC (Disitamab vedotin, a HER2-directed antibody-drug conjugate) in Combination with Pyrotinib for Trastuzumab-treated HER2-Positive Recurrent or Metastatic Breast Cancer: A Phase Ib/II Study
11天前
已完结
Hip and Knee Section, Treatment, One Stage Exchange: Proceedings of International Consensus on Orthopedic Infections
24天前
已完结
Advances in the research and application of neurokinin-1 receptor antagonists
1个月前
已完结
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
2个月前
已完结
New insights into the pathophysiology and risk factors for PONV
3个月前
已完结
防治关节置换术后恶心呕吐的研究进展
3个月前
已完结
基于FAERS数据库的艾塞那肽不良事件信号挖掘与分析
8个月前
已完结
基于FAERS数据库的达格列净不良事件信号挖掘与分析
8个月前
已完结
Evidence-Based Use of Perioperative Antibiotics in Otolaryngology
8个月前
已完结